磁括约肌增强术治疗慢性胃食管反流病结局的影响因素
该回顾性研究分析了170例接受磁括约肌增强术(MSA)的胃食管反流病(GERD)患者,中位随访48个月,47%获优效、28%良效、22%中等、3%差效。多因素分析显示BMI>35、结构性LES缺陷、术前LES残余压是优/良结局的独立负性预测因素。
要点
- MSA术后多数患者可获得优或良结局,但约四分之一结局不理想。
- BMI>35、结构性LES缺陷和高LES残余压预示MSA结局较差。
- MSA患者选择应综合考虑BMI、食管括约肌结构和功能。
核心结论
- MSA可使多数GERD患者获得优/良结局,但高BMI、结构性括约肌缺陷和术前LES残余压升高可能阻碍这一目标的实现。
研究设计与样本
- 回顾性分析两个数据库:Pivotal Trial(N=99)和前瞻性维护的食管数据库(N=71),共170例接受MSA的患者,中位年龄53岁(IQR 43-60),中位BMI 27(IQR 24-30)。
主要发现
- MSA术后中位48个月(IQR 19-60),优效结局47%,良效28%,中等22%,差效3%。
- 术后中位DeMeester评分15.6(IQR 5.8-26.6),食管炎发生率17.6%,每日PPI使用率17%。
- 单因素分析显示BMI、术前LES残余压、Hill分级和食管裂孔疝对优/良结局有负面影响。
关键数值与推荐
- 优效结局定义为GERD-HRQL<5、无PPI使用、无食管炎;良效为GERD-HRQL 6-15、无PPI使用、A级食管炎;中等为GERD-HRQL 16-25、使用PPI、B级食管炎;差效为GERD-HRQL>25、使用PPI、C/D级食管炎。
临床怎么用
- MSA术前应评估BMI、LES结构和功能(残余压),高BMI(>35)、结构性LES缺陷和高LES残余压患者可能不适合MSA或需谨慎选择。
- MSA术后多数患者可停用PPI且食管炎控制良好,但需长期随访监测结局。
局限性
- 回顾性研究设计,样本量有限(N=170),随访时间中位48个月,可能存在选择偏倚和信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Magnetic sphincter augmentation (MSA) is a surgical treatment option for patients with gastroesophageal reflux disease (GERD). MSA consistently improves quality of life, maintains freedom from PPIs, and objectively controls GERD. However, up to 24% of patients did not achieve these outcomes. We sought to identify factors predicting outcomes after MSA placement with the aim of refining selection criteria. METHODS: We retrospectively analyzed clinical, endoscopic, manometric, pH data, and intraoperative factors from two databases: Pivotal Trial (N = 99) and our prospectively maintained esophageal database (N = 71). A priori outcomes were defined as excellent (GERD-HRQL <5, no PPI, no esophagitis), good (GERD-HRQL 6-15, no PPI, grade A esophagitis), fair (GERD-HRQL 16 to 25, PPI use, grade B esophagitis), and poor (GERD-HRQL >25, PPI use, grade C/D esophagitis). Univariable and multivariable logistic regression analyses were performed to determine predictors of achieving an excellent/good outcome. RESULTS: A total of 170 patients underwent MSA with a median age of 53 years, [43-60] and a median BMI of 27 (IQR = 24-30). At baseline, 93.5% of patients experienced typical symptoms and 69% atypical symptoms. Median DeMeester score was 37.9 (IQR 27.9-51.2) with a structurally intact sphincter in 47%. Esophagitis occurred in 43%. At 48 [19-60] months after MSA, excellent outcomes were achieved in 47%, good in 28%, fair in 22%, and poor in 3%. Median DeMeester score was 15.6 (IQR = 5.8-26.6), esophagitis in 17.6% and daily PPI use in 17%. At univariable analysis, excellent/good outcomes were negatively impacted by BMI, preoperative LES residual pressure, Hill grade, and hiatal hernia. At multivariable analysis, BMI >35 (OR = 0.05, 0.003-0.78, p = 0.03), structurally defective LES (OR = 0.37, 0.13-0.99, p = 0.05), and preoperative LES residual pressure (OR = 0.89, 0.80-0.98, p = 0.02) were independent negative predictors of excellent/good outcome. CONCLUSIONS: Magnetic sphincter augmentation results in excellent/good outcomes in most patients but a higher BMI, structurally defective sphincter, and elevated LES residual pressure may prevent this goal.
引用
- Warren HF, Brown LM, Mihura M, et al. Factors influencing the outcome of magnetic sphincter augmentation for chronic gastroesophageal reflux disease. Surg Endosc. 2017. PMID: 28664433. doi:10.1007/s00464-017-5696-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。